Virtual Seminar on eCTD Submissions of INDNDA to the US FDA, EU and Canada - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--May 23, 2019--
The “6-Hour Virtual Seminar on eCTD Submissions of INDNDA to the US FDA, EU and Canada” webinar has been added to ResearchAndMarkets.com’s offering.
This webinar will provide you with information to ensure that you are ready for implementing the mandated requirements of the CTD/eCTD. This webinar will provide you with information to ensure that you are ready for implementing the mandated requirements of the CTD/eCTD.
The international agreement to assemble all Quality, Safety and Efficacy information for a drug or biologic product into a common format (called the CTD - Common Technical Document) has improved the speed and efficiency for companies working in global development programs and clarified expectations by regulatory bodies.
Reformatting for multiple submissions is substantially limited. The CTD has improved the regulatory review processes and enabled implementation of good review practices. The eCTD has increased efficiency for reviewers and improved submission times. Beginning in May 2017, the eCTD will be required in the US for all marketing applications.
Who Should Attend:
Lecture 1 - CTD > eCTD
Lecture 2 - eCTD Preparation
For more information about this webinar visit https://www.researchandmarkets.com/r/tnp9kg
View source version on businesswire.com:https://www.businesswire.com/news/home/20190523005409/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Pharmaceutical Manufacturing
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 05/23/2019 08:53 AM/DISC: 05/23/2019 08:53 AM